| dc.contributor.author | Rodriguez-Morales, A.J. | |
| dc.contributor.author | Sah, R. | |
| dc.contributor.author | Millan-Oñate, J. | |
| dc.contributor.author | Gonzalez, A. | |
| dc.contributor.author | Montenegro-Idrogo, J.J. | |
| dc.contributor.author | Scherger, S. | |
| dc.contributor.author | Franco-Paredes, C. | |
| dc.contributor.author | Henao-Martínez, A.F. | |
| dc.date.accessioned | 2025-10-31T18:32:32Z | |
| dc.date.available | 2025-10-31T18:32:32Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12805/4684 | |
| dc.description.abstract | Invasive mycoses represent opportunistic infections occurring predominantly among highly immunosuppressed individuals, including those with advanced human immunodeficiency virus-associated immunosuppression, uncontrolled diabetes mellitus, drug-induced immunosuppression during transplantation, autoimmune disorders, or hematological malignancies. The overuse of high-dose glucocorticoids and the administration of highly immunosuppressive drugs such as inhibitors of the Janus kinase inhibitors or IL-6 receptor inhibitors to treat patients with the coronavirus disease 2019 (COVID-19) are responsible in part for the increasing number of life-threatening opportunistic infections identified in this patient population... | en_US |
| dc.description.sponsorship | We dedicate this Editorial to the memory of Dr. Francisco Miguel Marty, who died tragically in 2021. Dr. Marty is remembered as a gentle, well-rounded individual with extensive expertise in mucormycosis and other opportunistic infections, including mucormycosis in organ transplant recipients and patients with malignancies. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. | |
| dc.format | application/pdf | |
| dc.language.iso | eng | |
| dc.publisher | GE Publications | |
| dc.relation.ispartof | urn:issn:2049-937X | |
| dc.rights | https://purl.org/coar/access_right/c_abf2 | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | |
| dc.subject | SDG 3 | en_US |
| dc.subject | Invasive Fungal Infections and Antifungal Resistance | en_US |
| dc.subject | Mucormycosis: Emerging Fungal Infections and Treatments | en_US |
| dc.title | COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs | en_US |
| dc.type | https://purl.org/coar/resource_type/c_b239 | |
| dc.identifier.doi | https://doi.org/10.1177/20499361211027065 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.05 | |
| dc.type.other | Editorial | |
| dc.identifier.journal | Therapeutic Advances in Infectious Disease | |
| dc.type.version | https://purl.org/coar/version/c_970fb48d4fbd8a85 | |